PEspeaks

Feb 20, 2018
In the coming weeks, the EU will decide if the degree of protection offered to drug firms by research incentives such as the SPC are really in the interests of patients and society. Reflector reports.
Feb 16, 2018
Rather than looking at what their peers are doing in digital health, pharma companies need to anticipate new challengers in the healthcare industry, writes Kal Patel.
Feb 15, 2018
Pharmaceutical Executive
This blog discusses the benefits of the pharma industry adopting the idea that media is data.
Feb 06, 2018
Pharmaceutical Executive
Drawing parallels from the world of football coaching in evaluating and grooming future C-suite pharma leaders—call it the quest to see "what right looks like?"
Feb 06, 2018
Pharmaceutical Executive
Julian Upton assembles a few rare slivers of positivity on UK pharma's future.
Feb 06, 2018
Pharmaceutical Executive
Low-cost follow-ons and biosimilars please payers but heighten competitive battles with brands.
Feb 05, 2018
Amid the clamor for government action to curb prescription drug prices, a more collaborative effort aims to consider the full range of healthcare services and rates that affect spending in this area.
Feb 04, 2018
Professor Carole Longson's move from NICE to the ABPI is another appointment that helps to square the balance between UK industry and Government. Leela Barham reports.
Feb 02, 2018
Pharmaceutical Executive
Are the technologies and assumptions at the heart of healthcare AI trustworthy?
Jan 30, 2018
Pharmaceutical Executive
But how much better would our creative be if we took the time to really listen to what our clients are saying – and what they are not saying – rather than reading between the lines of an RFP?
native1_300x100
lorem ipsum